Skip to main content
Home

Main navigation

  • Home
  • About
  • Team
  • Investments
  • News
  • Contact
Radius Health
December 19, 2022
EU Approves ELADYNOS (Abaloparatide) for Osteoporosis in Postmenopausal Women

Read

Crossover Health logo
November 10, 2022
Crossover Health Launches New Health Plan Benefit

Read

Naveris logo
October 24, 2022
Naveris Collaborators Present Award-winning Abstract at ASTRO 2022

Read

Corium Pharma Solutions logo
October 20, 2022
Manufacturing Business Acquisition and a $100 Million Neuroscience Therapeutics Investment by Webster Equity Partners

Read

Radius Health
October 12, 2022
Radius Appoints Scott Briggs as Chief Executive Officer and Member of the Board

Read

Corium International logo
September 29, 2022
Corium Launches ADLARITY® (donepezil transdermal system) for Patients with Alzheimer’s Dementia

Read

Naveris logo
September 19, 2022
Naveris, Inc. Raises $51 Million to Advance Commercialization of NavDx

Read

Radius Health
August 15, 2022
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.

Read

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Gurnet Point Capital
55 Cambridge Parkway
Suite 401
Cambridge, MA 02142

Contact Us

Gurnet Point Capital © 2023. Please take a moment to read the Legal Notice / Privacy Statement.